{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:40:07Z","timestamp":1726245607437},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2002,8,28]],"date-time":"2002-08-28T00:00:00Z","timestamp":1030492800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/1471-2334-2-17","type":"journal-article","created":{"date-parts":[[2002,9,27]],"date-time":"2002-09-27T11:09:55Z","timestamp":1033124995000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV-infected patients with chronic hepatitis C"],"prefix":"10.1186","volume":"2","author":[{"given":"Raffaele","family":"Bruno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Sacchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Puoti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Ciappina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Zocchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Maffezzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Capelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savino FA","family":"Patruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonello","family":"Malfitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"Filice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,8,28]]},"reference":[{"issue":"1","key":"41_CR1","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1086\/520144","volume":"29","author":"CT Staples Jr","year":"1999","unstructured":"Staples CT, Rimland D, Dudas D: Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival. Clin Infect Dis. 1999, 29 (1): 150-4.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"41_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/00002030-199804000-00006","volume":"12","author":"L Piroth","year":"1998","unstructured":"Piroth L, Duong M, Quantin C, et al: Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients?. AIDS. 1998, 12 (4): 381-8. 10.1097\/00002030-199804000-00006.","journal-title":"AIDS"},{"issue":"6","key":"41_CR3","first-page":"602","volume":"6","author":"ME Eyster","year":"1993","unstructured":"Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ: Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr. 1993, 6 (6): 602-10.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"41_CR4","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/0016-5085(89)90405-8","volume":"97","author":"P Martin","year":"1989","unstructured":"Martin P, Di BA, Kassianides C, Lisker-Melman M, Hoofnagle J: Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology. 1989, 97 (6): 1559-61.","journal-title":"Gastroenterology"},{"issue":"2","key":"41_CR5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1053\/jhep.2001.26517","volume":"34","author":"Y Benhamou","year":"2001","unstructured":"Benhamou Y, Di MV, Bochet M, et al: Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy. Hepatology. 2001, 34 (2): 283-7. 10.1053\/jhep.2001.26517.","journal-title":"Hepatology"},{"issue":"6","key":"41_CR6","first-page":"269","volume":"3","author":"J Rockstroh","year":"1998","unstructured":"Rockstroh J, Woitas R, Spengler U: Human immunodeficiency virus and hepatitis C virus coinfection. Eur J Med Res. 1998, 3 (6): 269-77.","journal-title":"Eur J Med Res"},{"issue":"Suppl 1","key":"41_CR7","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1086\/313842","volume":"30","author":"MS Sulkowski","year":"2000","unstructured":"Sulkowski MS, Mast EE, Seeff LB, Thomas DL: Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clin Infect Dis. 2000, 30 (Suppl 1): S77-84. 10.1086\/313842.","journal-title":"Clin Infect Dis"},{"issue":"13","key":"41_CR8","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1056\/NEJM199803263381301","volume":"338","author":"F Palella","year":"1998","unstructured":"Palella F, Delaney K, Moorman A, et al: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998, 338 (13): 853-60. 10.1056\/NEJM199803263381301.","journal-title":"N Engl J Med"},{"issue":"4","key":"41_CR9","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/infdis\/165.4.723","volume":"165","author":"N Boyer","year":"1992","unstructured":"Boyer N, Marcellin P, Degott C, et al: Recombinant interferon-alpha for chronic hepatitis C in patients positive for antibody to human immunodeficiency virus. Comite des Anti-Viraux. J Infect Dis. 1992, 165 (4): 723-6.","journal-title":"J Infect Dis"},{"issue":"2","key":"41_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/jmv.1890400206","volume":"40","author":"E Marriott","year":"1993","unstructured":"Marriott E, Navas S, del RJ, et al: Treatment with recombinant alpha-interferon of chronic hepatitis C in anti-HIV-positive patients. J Med Virol. 1993, 40 (2): 107-11.","journal-title":"J Med Virol"},{"issue":"3","key":"41_CR11","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/clinids\/23.3.585","volume":"23","author":"V Soriano","year":"1996","unstructured":"Soriano V, Garcia-Samaniego J, Bravo R, et al: Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Hepatitis-HIV Spanish Study Group. Clin Infect Dis. 1996, 23 (3): 585-91.","journal-title":"Clin Infect Dis"},{"issue":"21","key":"41_CR12","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","volume":"339","author":"J McHutchison","year":"1998","unstructured":"McHutchison J, Gordon S, Schiff E, et al: Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med. 1998, 339 (21): 1485-92. 10.1056\/NEJM199811193392101.","journal-title":"N Engl J Med"},{"issue":"9138","key":"41_CR13","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/S0140-6736(98)07124-4","volume":"352","author":"T Poynard","year":"1998","unstructured":"Poynard T, Marcellin P, Lee S, et al: Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet. 1998, 352 (9138): 1426-32. 10.1016\/S0140-6736(98)07124-4.","journal-title":"Lancet"},{"issue":"5","key":"41_CR14","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1053\/jhep.2000.19347","volume":"32","author":"T Poynard","year":"2000","unstructured":"Poynard T, McHutchison J, Davis G, et al: Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C. Hepatology. 2000, 32 (5): 1131-7. 10.1053\/jhep.2000.19347.","journal-title":"Hepatology"},{"issue":"4794","key":"41_CR15","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1126\/science.2435003","volume":"235","author":"M Vogt","year":"1987","unstructured":"Vogt M, Hartshorn K, Furman P, et al: Ribavirin antagonizes the effect of azidothymidine on HIV replication. Science. 1987, 235 (4794): 1376-9.","journal-title":"Science"},{"issue":"9252","key":"41_CR16","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/S0140-6736(00)03618-7","volume":"357","author":"A Lafeuillade","year":"2001","unstructured":"Lafeuillade A, Hittinger G, Chadapaud S: Increased mitochondrial toxicity with ribavirin in HIV\/HCV coinfection. Lancet. 2001, 357 (9252): 280-1. 10.1016\/S0140-6736(00)03618-7.","journal-title":"Lancet"},{"issue":"5","key":"41_CR17","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1053\/jhep.2001.29130","volume":"34","author":"S Sauleda","year":"2001","unstructured":"Sauleda S, Juarez A, Esteban J, et al: Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus-infected patients with congenital coagulation disorders [In Process Citation]. Hepatology. 2001, 34 (5): 1035-40. 10.1053\/jhep.2001.29130.","journal-title":"Hepatology"},{"key":"41_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2165\/00044011-199918010-00002","volume":"18","author":"R Bruno MD","year":"1999","unstructured":"Bruno MD R, Sacchi P, Maffezzini E, Zara F, Brunetti E, Filice C, Patruno SFA, Filice G: Daily Interferon regimen for chronic hepatitis C. A prospective randomized study. Clin Drug Invest. 1999, 18: 11-16.","journal-title":"Clin Drug Invest"},{"key":"41_CR19","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/hep.1840010511","volume":"1","author":"RGIK Knodell","year":"1981","unstructured":"Knodell RGIK, Black WC: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981, 1: 431-435.","journal-title":"Hepatology"},{"issue":"22","key":"41_CR20","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1001\/archinte.160.22.3365","volume":"160","author":"M Bonacini","year":"2000","unstructured":"Bonacini M, Puoti M: Hepatitis C in patients with human immunodeficiency virus infection: diagnosis, natural history, meta-analysis of sexual and vertical transmission, and therapeutic issues. Arch Intern Med. 2000, 160 (22): 3365-73. 10.1001\/archinte.160.22.3365.","journal-title":"Arch Intern Med"},{"issue":"3","key":"41_CR21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0924-8579(00)00259-4","volume":"16","author":"T Prestileo","year":"2000","unstructured":"Prestileo T, Mazzola G, Di LF, et al: Response-adjusted alpha-interferon therapy for chronic hepatitis C in HIV-infected patients. Int J Antimicrob Agents. 2000, 16 (3): 373-8. 10.1016\/S0924-8579(00)00259-4.","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"41_CR22","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/00126334-200012010-00014","volume":"25","author":"R Bruno","year":"2000","unstructured":"Bruno R, Sacchi P, Filice C, Filice G: Aggressive daily interferon therapy in HIV-HCV coinfected patients. J Acquir Immune Defic Syndr. 2000, 25 (4): 372-3.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"41_CR23","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1046\/j.1365-2516.2000.00444.x","volume":"6","author":"K Hayashi","year":"2000","unstructured":"Hayashi K, Fukuda Y, Nakano I, et al: Poor response to interferon treatment for chronic hepatitis C in human immunodeficiency virus-infected haemophiliacs. Haemophilia. 2000, 6 (6): 677-81. 10.1046\/j.1365-2516.2000.00444.x.","journal-title":"Haemophilia"},{"issue":"16","key":"41_CR24","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1097\/00002030-200111090-00010","volume":"15","author":"A Landau","year":"2001","unstructured":"Landau A, Batisse D, Piketty C, et al: Long-term efficacy of combination therapy with interferon-alpha2b and ribavirin for severe chronic hepatitis C in HIV-infected patients [In Process Citation]. AIDS. 2001, 15 (16): 2149-55. 10.1097\/00002030-200111090-00010.","journal-title":"AIDS"},{"issue":"14","key":"41_CR25","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1097\/00002030-200109280-00006","volume":"15","author":"G Nasti","year":"2001","unstructured":"Nasti G, Di GG, Tavio M, et al: Chronic hepatitis C in HIV infection: feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirin. AIDS. 2001, 15 (14): 1783-7. 10.1097\/00002030-200109280-00006.","journal-title":"AIDS"},{"issue":"6","key":"41_CR26","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0149-2918(00)90004-3","volume":"22","author":"T Kakuda","year":"2000","unstructured":"Kakuda T: Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Ther. 2000, 22 (6): 685-708. 10.1016\/S0149-2918(00)90004-3.","journal-title":"Clin Ther"},{"key":"41_CR27","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1136\/sti.77.3.158","volume":"77","author":"A White","year":"2001","unstructured":"White A: Mitochondrial toxicity and HIV therapy. Sex Transm Inf. 2001, 77: 158-173. 10.1136\/sti.77.3.158.","journal-title":"Sex Transm Inf"},{"issue":"10","key":"41_CR28","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1023\/A:1026613116942","volume":"43","author":"T Wiley","year":"1998","unstructured":"Wiley T, Briedi L, Lam N, Layden T: Early HCV RNA values after interferon predict response. Dig Dis Sci. 1998, 43 (10): 2169-72. 10.1023\/A:1026613116942.","journal-title":"Dig Dis Sci"},{"key":"41_CR29","unstructured":"Soriano VG-SJ, Perez-Olmeda M, Barreiro P, Nunez M, Rodriguez-Rosado R: Pegylated Interferon plus ribavirin for the treatment of chronic hepatitis C in HIV infected patients. 1st IAS Conference on HIV pathogenesis and treatment. Buenos Aires. July 8\u201311. 2001"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-2-17.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-2-17\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-2-17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-2-17.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T15:56:29Z","timestamp":1726242989000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-2-17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8,28]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2002,12]]}},"alternative-id":["41"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-2-17","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2002,8,28]]},"assertion":[{"value":"26 April 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"17"}}